These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17241530

  • 21. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Rauko P, Novotny L, Mego M, Saiko P, Schott H, Szekeres T.
    Neoplasma; 2007; 54(1):68-74. PubMed ID: 17203895
    [Abstract] [Full Text] [Related]

  • 22. [A new antileukemic drug, cytarabine ocfosfate].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1877-83. PubMed ID: 8379682
    [Abstract] [Full Text] [Related]

  • 23. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    Rubas W, Supersaxo A, Weder HG, Hartmann HR, Hengartner H, Schott H, Schwendener R.
    Int J Cancer; 1986 Jan 15; 37(1):149-54. PubMed ID: 3941019
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway.
    Kotra LP, Manouilov KK, Cretton-Scott E, Sommadossi JP, Boudinot FD, Schinazi RF, Chu CK.
    J Med Chem; 1996 Dec 20; 39(26):5202-7. PubMed ID: 8978848
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
    Schwendener R, Schott H.
    Methods Enzymol; 2005 Dec 20; 391():58-70. PubMed ID: 15721374
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sustained delivery of cytarabine-loaded vesicular phospholipid gels for treatment of xenografted glioma.
    Qi N, Cai C, Zhang W, Niu Y, Yang J, Wang L, Tian B, Liu X, Lin X, Zhang Y, Zhang Y, He H, Chen K, Tang X.
    Int J Pharm; 2014 Sep 10; 472(1-2):48-55. PubMed ID: 24914829
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CNS delivery of L-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug.
    Pinnen F, Cacciatore I, Cornacchia C, Mollica A, Sozio P, Cerasa LS, Iannitelli A, Fontana A, Nasuti C, Di Stefano A.
    Amino Acids; 2012 Jan 10; 42(1):261-9. PubMed ID: 21080012
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. N4-(dialkylamino)methylene derivatives of 2'-deoxycytidine and arabinocytidine: physicochemical studies for potential prodrug applications.
    Kerr SG, Kalman TI.
    J Pharm Sci; 1994 Apr 10; 83(4):582-6. PubMed ID: 8046619
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.